Hürthle cell tumours of the thyroid. A review with emphasis on mitochondrial abnormalities with clinical relevance
- PMID: 10993269
- DOI: 10.1007/s004280000219
Hürthle cell tumours of the thyroid. A review with emphasis on mitochondrial abnormalities with clinical relevance
Abstract
The molecular and enzymatic abnormalities of mitochondria in oxyphilic / oncocytic / Hürthle cells and their respective tumours are reviewed in a series of sections: "Mitochondria, ageing, neurodegenerative diseases and cancer", "Mitochondrial abnormalities in Hürthle cells and Hürthle cells tumours", "Mitochondrion-related alterations in tumours with and without Hürthle cell/oncocytic features", "True and secondary oxyphilia", and "Bcl-2 expression, apoptosis and necrosis in Hürthle cell tumours and tumour-like lesions". The clinicopathological and pathogenetic meaning of the data on record on these topics are discussed, with an emphasis on thyroid pathology.
Similar articles
-
Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid.Br J Cancer. 2005 May 23;92(10):1892-8. doi: 10.1038/sj.bjc.6602547. Br J Cancer. 2005. PMID: 15841082 Free PMC article.
-
Hürthle (oncocytic) cell tumors of thyroid: etiopathogenesis, diagnosis and clinical significance.Int J Surg Pathol. 2005 Jan;13(1):29-35. doi: 10.1177/106689690501300104. Int J Surg Pathol. 2005. PMID: 15735852 Review.
-
Reduced HBME-1 immunoreactivity of papillary thyroid carcinoma and papillary thyroid carcinoma-related neoplastic lesions with Hürthle cell and/or apocrine-like changes.Histopathology. 2002 Feb;40(2):133-42. doi: 10.1046/j.1365-2559.2002.01315.x. Histopathology. 2002. PMID: 11952857
-
Core I gene is overexpressed in Hürthle and non-Hürthle cell microfollicular adenomas and follicular carcinomas of the thyroid.BMC Cancer. 2004 Mar 25;4:12. doi: 10.1186/1471-2407-4-12. BMC Cancer. 2004. PMID: 15043758 Free PMC article.
-
Hürthle cell lesions of the thyroid: Progress made and challenges remaining.Cancer Cytopathol. 2021 May;129(5):347-362. doi: 10.1002/cncy.22375. Epub 2020 Oct 27. Cancer Cytopathol. 2021. PMID: 33108684 Review.
Cited by
-
Oncocytic Change in Thyroid Pathology.Front Endocrinol (Lausanne). 2021 May 3;12:678119. doi: 10.3389/fendo.2021.678119. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34012422 Free PMC article. Review.
-
Molecular pathology of well-differentiated thyroid carcinomas.Virchows Arch. 2005 Nov;447(5):787-93. doi: 10.1007/s00428-005-0065-5. Epub 2005 Sep 28. Virchows Arch. 2005. PMID: 16189702 Review.
-
Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid.Br J Cancer. 2005 May 23;92(10):1892-8. doi: 10.1038/sj.bjc.6602547. Br J Cancer. 2005. PMID: 15841082 Free PMC article.
-
Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell Carcinoma.Cancer Cell. 2018 Aug 13;34(2):242-255.e5. doi: 10.1016/j.ccell.2018.06.013. Cancer Cell. 2018. PMID: 30107175 Free PMC article.
-
Molecular genetics and diagnosis of thyroid cancer.Nat Rev Endocrinol. 2011 Aug 30;7(10):569-80. doi: 10.1038/nrendo.2011.142. Nat Rev Endocrinol. 2011. PMID: 21878896 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical